From the Guidelines
The management of MRI-diagnosed discitis prior to organism identification should prioritize empiric broad-spectrum antibiotic therapy, pain management, and spine immobilization, while awaiting culture results to guide targeted therapy, as recommended by the 2015 Infectious Diseases Society of America (IDSA) guidelines 1. The approach to managing MRI-diagnosed discitis involves several key components, including:
- Empiric broad-spectrum antibiotic therapy to cover common pathogens such as Staphylococcus aureus (including MRSA) and gram-negative organisms
- Pain management using NSAIDs, muscle relaxants, and sometimes opioids for severe pain
- Spine immobilization with a brace to provide stability and reduce pain
- Bed rest initially, with gradual mobilization as symptoms improve
- Surgical intervention reserved for cases with neurological deficits, spinal instability, or failure of conservative treatment It is essential to obtain blood cultures before starting antibiotics and to consider a CT-guided biopsy of the affected disc to identify the causative organism, as suggested by the IDSA guidelines 1 and supported by the American College of Radiology 2. The choice of empiric antibiotics should be guided by the most likely pathogens, with a common regimen being vancomycin (15-20 mg/kg IV every 8-12 hours, adjusted for renal function) plus a third-generation cephalosporin like ceftriaxone (2g IV daily) or a fluoroquinolone such as ciprofloxacin (400mg IV every 12 hours), as recommended by the IDSA guidelines 1. The use of MRI in diagnosing discitis is well-established, with a sensitivity of 96%, specificity of 94%, and accuracy of 92% 2, making it a crucial tool in guiding management decisions. Overall, the management of MRI-diagnosed discitis prior to organism identification requires a comprehensive approach that prioritizes empiric antibiotic therapy, pain management, and spine immobilization, while awaiting culture results to guide targeted therapy.
From the Research
Management of MRI Diagnosed Discitis Prior to Organism Identification
- The management of MRI diagnosed discitis prior to organism identification typically involves the use of intravenous antibiotics, with flucloxacillin or ceftriaxone being common choices 3, 4.
- It is widely recommended to perform blood cultures and CT-guided biopsies before starting antibiotics, but it is unclear how long to withhold antibiotics if cultures remain negative 3.
- The use of CT-guided sampling for culture before commencing antibiotics can increase organism detection and reduce the duration of antibiotic treatment 3.
- In some cases, treatment may involve six weeks of intravenous antibiotics followed by six weeks of oral therapy, although the optimal duration of treatment is not well established 3, 4.
- The choice of antibiotic may be guided by the suspected causative organism, with Staphylococcus aureus being a common cause of discitis 3, 4.
- Image-guided biopsy can provide meaningful information to impact clinical management, particularly in cases where the causative organism is unknown or suspected to be resistant to empiric antibiotics 5.
- MRI and CT imaging can help identify the best target structures for biopsy and increase the likelihood of positive cultures, with MRI being more sensitive in the acute phase of spondylodiscitis 6.
Factors Associated with Biopsy Yield
- Elevated ESR and epidural collection on MRI have been associated with higher biopsy yield in patients with discitis-osteomyelitis 5.
- The presence of certain MRI findings, such as extensive hyperintensity of vertebral body and/or disc on Short Tau Inversion Recovery-T2w images, paravertebral collections, preserved or augmented disc height, and vertebral fractures, can be predictive of positive cultures 6.
Antibiotic Treatment
- Levofloxacin may be an effective alternative oral antimicrobial agent in cases where the susceptibility of the causative organism is unknown or suspected to be resistant to empiric antibiotics 7.
- The choice of antibiotic should be guided by the suspected causative organism and local resistance patterns, as well as the results of any available susceptibility testing 3, 4, 7.